Morgan Stanley Downgrades China Biologic Products (CBPO) to Equalweight
Tweet
Share
E-mailGet Alerts CBPO Hot Sheet
Price: $119.99 --0%
Rating Summary:
3 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Rating Summary:
3 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Join SI Premium – FREE
Morgan Stanley analyst Yolanda Hu downgraded China Biologic Products (NASDAQ: CBPO) from Overweight to Equalweight with a price target of $84.00 (from $90.00).
For an analyst ratings summary and ratings history on China Biologic Products click here. For more ratings news on China Biologic Products click here.
Shares of China Biologic Products closed at $69.14 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Downgrades Brother Industries Ltd (6448:JP) to Neutral
- Deutsche Bank Downgrades SentinelOne Inc (S) to Hold on Valuation
- Japan Post Holdings Co., Ltd (6178:JP) (JPHLF) PT Raised to JPY2,200 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
